bibliographicCitation |
Wang X, Yao F, Liu N, Wu Y, Zheng X, Li J, Liu C, Qiu X, Jin F. Clinical implications of HER-2 and P53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer. Cancer Biology & Medicine. 2008 Dec 07;5(6):424. doi: 10.1007/s11805-008-0424-5. |